Everything Is Tuberculosis: The History and Persistence of Our Deadliest ... - critical summary review

Ask around and most people will tell you tuberculosis is a disease from old novels. Coughing poets. Pale heroines. Something the twentieth century took care of, like corsets or telegrams. The truth is harder to hold: TB killed 1.25 million people in 2023, more than any other infectious disease on Earth. And it has been curable since the 1950s.

Sit with those two facts side by side. We have the drugs. We have the tests. We have seventy years of proof that a person with tuberculosis can walk out of a clinic healthy. And still, every twenty seconds or so, somebody dies of it. That is not a scientific failure. It is a distribution failure, and distribution is another word for priorities.

John Green, the novelist behind The Fault in Our Stars, went to Sierra Leone in 2019 expecting to report on maternal health. He came back with a different obsession: a teenager named Henry, and the long, strange, unfinished story of why the world's oldest killer is still killing. What follows is that story — part history, part detective work, part accusation. It moves from cowboy hats to colonial railroads, from a German laboratory to a hospital ward with no running water. And it lands on an uncomfortable idea: tuberculosis is shaped less by biology than by us.

The Geography of an Epidemic

Green's first visit to Lakka Government Hospital in Sierra Leone was supposed to be a quick tour. A staff member steered him toward the tuberculosis ward, and there he met Henry, a severely emaciated 17-year-old boy. Green assumed he was nine. Years of illness and hunger had stunted him that badly. The boy happened to share a name with Green's own son.

The ward had no dependable electricity, no running water, and not enough food. That last shortage sounds minor. It isn't. TB medicine works by killing bacteria, and as it works, appetite comes roaring back. Patients who finally feel hungry discover they have nothing to eat. Many walk out to find food or work. Half-treated bacteria survive, adapt, and come back stronger. Poverty doesn't just accompany the disease. It manufactures the resistant version of it.

None of this fell from the sky. Sierra Leone's poverty was engineered, and you can see the blueprint on a map: colonial railroads that only connected mineral-rich areas to ports. Nothing linked towns to each other. Everything pointed outward, toward extraction. Henry's mother, Isatu, grew up happy in a village before the 1991 civil war pushed her family into Freetown with nothing. A century of taking things out of a country leaves a shape. Henry was born inside that shape.

The Mythology of Consumption

Tuberculosis has fingerprints in the oddest places. John B. Stetson headed west in the 1860s chasing the "travel cure," the belief that dry mountain air could heal consumptive lungs. Out there he designed a wide-brimmed hat — and invented the look of the American cowboy. New Mexico recruited white TB patients partly to boost its English-speaking population and win statehood. And in Sarajevo in 1914, the teenagers who carried out the assassination of Archduke Franz Ferdinand were largely fearless because several already had terminal TB. A dying boy has little to lose.

The disease itself is ancient and ruthlessly patient. Its scars appear in Egyptian mummies. Mycobacterium tuberculosis hides inside the very immune cells sent to destroy it, walls itself into hard little nodules, and can lie dormant for decades. Then come the night sweats, the vanishing weight, and finally bright arterial blood in a handkerchief. For centuries physicians could only guess at all this, because the inside of a living body was completely invisible to them.

So people invented meaning instead. The nineteenth century decided consumption sharpened the soul — a notion called spes phthisica, the idea that dying lungs produced artistic genius. Women used belladonna to dilate pupils and powder to mimic the pallor of the dying. Doctors called it a disease of civilization, one that supposedly struck sensitive, educated white people and spared colonized populations. That last part was a lie that killed millions, because it let colonial medicine simply not look.

The Bacillus and the Blame

On March 24, 1882, Robert Koch stood before Berlin's Physiological Society and presented the bacterium behind tuberculosis. He had already proven with anthrax that a specific microbe causes a specific disease. Now he'd stained, isolated, and photographed the culprit. Romance collapsed overnight. TB wasn't a delicate inheritance of the soul. It was contagious, and it was in the air of crowded tenements.

You'd think proof would produce compassion. Instead, it produced blame. If germs travel through filth and crowding, then high death rates among Black Americans got reinterpreted not as evidence of poverty and segregation, but as evidence of supposed racial weakness. The cruelest example is the Canadian residential schools, where Indigenous children died of tuberculosis at staggering rates. Officials knew. Reports were written. Almost nothing changed. Neglect that deliberate is not neglect.

Koch himself became a cautionary tale. Pushed by nationalist rivalry with Louis Pasteur, he announced a cure in 1890 — tuberculin, marketed as Koch's Serum. Patients flooded Berlin. Many died. Among the visitors was a young doctor named Arthur Conan Doyle, who examined the evidence and concluded the substance destroyed infected tissue without killing the bacteria. He was right. Tuberculin failed as a cure and survived as something else: the skin test still used to detect infection.

The Illusion of Control

Henry was six when the fevers and drenching night sweats started. He was diagnosed and put on the standard four-drug protocol known as RIPE — rifampin, isoniazid, pyrazinamide, ethambutol. Then his father stopped the treatment and took him to a faith healer. It is easy to judge that from a distance. It's harder when you learn that Henry's sister, Favor, died of a treatable throat cyst because the family couldn't afford the surgery. When medicine has already failed your family, faith is not irrational. It's what's left.

Wealthy countries had their own strange relationship with obedience. Before antibiotics, the sanatorium was the answer: fresh air, forced rest, total supervision. Gale Perkins entered one as a child and spent twelve years there. Patients were told when to speak and when to sit still. Crying was treated as a symptom to be punished.

This is the dynamic Green calls control over care — a system more invested in compliance than in comfort. Patients became inmates whose job was to trust doctors absolutely, even when the doctors had nothing that worked. That instinct never fully died. It just moved to poorer countries, where it would do far more damage.

A Cure Withheld

Then, astonishingly, it worked. Chest X-rays, pioneered in part by the trans physician Alan Hart, allowed early detection. The BCG vaccine offered children partial protection. Streptomycin arrived in the 1940s, followed by isoniazid and pyrazinamide. Alone, each drug bred resistance. Combined into the RIPE protocol, they cured. Sanatoria in the United States and Europe emptied so fast that buildings were sold off or abandoned.

Notice what did not happen. The cure did not travel. In the countries that had been mined, enslaved, and drained for centuries, death rates stayed catastrophic. The medicine existed; the delivery didn't.

What poor countries eventually got was DOTS — directly observed therapy, short-course — a strategy built around the cheapest possible tools. It relied on smear microscopy, which misses many cases and cannot detect drug resistance at all. When patients failed to improve, the label applied was "noncompliant." Paul Farmer documented a Haitian patient named Robert who was called noncompliant while walking hours to a clinic, unfed, with no money for transport. The word blamed him for a system that had never been built for him.

The Manufactured Superbug

Drug-resistant tuberculosis — MDR-TB — is not a natural disaster. It is the residue of interrupted treatment, missing drugs, and diagnostics too expensive to use. And the pharmaceutical response to it was a 46-year gap. Between 1966 and 2012, not a single new TB drug reached the market. The disease had stopped killing rich people, so it stopped being profitable.

When bedaquiline finally arrived, largely developed with public money, Johnson & Johnson priced it out of reach for the patients who needed it most. In India, a teenager named Shreya Tripathi sued her own government for access and won. The drug reached her. It came too late to repair her lungs, and she died. Her case forced a door open for others — a door that should never have been locked.

Wealthy nations talk about tuberculosis as a future nightmare, a superbug that might one day sweep the globe. That nightmare is the present tense for billions of people, not because the bacteria are unbeatable but because the treatment is rationed. Compare the response: COVID-19 got vaccines in under a year. TB got forty-six years of silence. Urgency, it turns out, is a resource distributed like any other.

The True Cost of Cost-Effectiveness

Dr. Girum Tefera, an Ethiopian physician running the ward at Lakka, spends his days fighting arithmetic. He knows what stops transmission: finding cases early with mobile X-rays, testing fast, treating before lungs are destroyed. The tool that does this best is GeneXpert molecular testing, which identifies TB and drug resistance in about two hours. Each cartridge was sold by Cepheid, a Danaher subsidiary, at a price that analysts estimated to be several times the cost of production. So hospitals ration tests, and patients get diagnosed too late.

Henry was one of those patients. His regimen included injectables so toxic they routinely cause permanent deafness, and they weren't working. He lost weight he didn't have. Then his closest friend on the ward, Thompson, died of the same disease, and Henry understood exactly what he was watching.

His father came to take him home to die, furious at years of promises. In a tense confrontation, Dr. Girum begged him for more time, offering to take the man's anger physically if the new drugs failed. Isatu and Henry chose to stay. That is what "cost-effectiveness" looks like on the ground: a doctor bargaining with a grieving father because the right medicine was priced for someone else's budget.

Breaking the Cycle

Tuberculosis surged again in the 1980s alongside the HIV/AIDS syndemic, each disease making the other deadlier. Antiretrovirals existed while millions died without them, defended by arguments so racist they're hard to repeat — including the claim that African patients couldn't follow a dosing schedule. Activists refused that logic, patents cracked, prices collapsed, and programs like PEPFAR and the Global Fund saved millions of lives. Proof that the barrier was never biology.

Henry's own turn came when Partners In Health funded and shipped a personalized combination of newer drugs. Within weeks his lymph nodes shrank and the weight came back. Months later he was no longer infectious, and after three years in hospitals he went home to a leaky, unlit apartment — alive. Throughout, he wrote poetry, including a poem called "Golden Axe," holding onto faith and his mother. He later returned to school, passed his exams, and earned a place at the University of Sierra Leone.

Then the cycle can run the other direction. Phumeza Tisile, who survived MDR-TB in South Africa and lost her hearing to it, challenged Johnson & Johnson's attempt to extend its bedaquiline patent in an Indian court — and won. Generic prices fell for everyone who came after. That is what the social determinants of health look like when someone fights them. Green points to a global push called Search, Treat, Prevent, estimated at roughly $25 billion a year, which would end tuberculosis and repay the world many times over.

Final notes

A disease we learned to cure seventy years ago still kills over a million people a year. That gap isn't biological. It's built from prices, patents, and quiet decisions about whose life is worth the cost. Henry lived because a handful of people refused the arithmetic. Tuberculosis stopped being a medical mystery long ago; what remains is a choice we keep making.